| Date | Time | Source | Headline | Symbol | Company |
| 10/16/2023 | 4:44PM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/09/2023 | 7:33AM | IH Market News | Monday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and more | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 6:21PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 6:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 6:08PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 6:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 6:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 5:59PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 5:54PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 5:51PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:30PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:28PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:26PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:24PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:22PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:20PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:18PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:16PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:13PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:11PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:08PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/06/2023 | 8:30AM | Business Wire | Rule 17(e) Announcement - Horizon Therapeutics plc | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/05/2023 | 7:40AM | Business Wire | Rule 17(d) Announcement – Horizon Therapeutics plc | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/05/2023 | 7:32AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/03/2023 | 11:15AM | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/03/2023 | 11:06AM | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/02/2023 | 11:39AM | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/02/2023 | 11:24AM | Business Wire | Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |
| 10/02/2023 | 8:00AM | Business Wire | Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 | NASDAQ:HZNP | Horizon Therapeutics Public Limited Company |